Key Points Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better. Compass Pathways said new ...
Joe Antinozzi’s Houston-based broker team is leaving Remax for Robert Reffkin’s brokerage in a move motivated by technology.
Compass Pathways (CMPS) stock gains as Evercore ISI upgraded the company on the latest Phase 3 trial data for the company's ...
3don MSN
Compass Pathways highlights long-term data from resistant depression, backs 2027 launch timeline
Compass Pathways plc CMPS on Wednesday reported 26-week results from Part B of its Phase 3 COMP006 trial, reinforcing the ...
Compass Pathways Plc shares fell almost 10% Tuesday after a pivotal study of its experimental psilocybin-based therapy ...
Compass Pathways (CMPS) stock rises as the company posts new late-stage trial data for its psychedelic therapy COMP360 ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the 26-week results (Part B) from its second ongoing ...
Or, if you prefer, you can use the "Download Zip" button available through the main repository page. Downloading the project as a .ZIP file will keep the size of the ...
Welcome to CHRS Training and Instructions for employees! We provide foundational training through online job aids -- including instructions, videos, and other resources -- as outlined in the left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results